latest news on glp 1 Fmr. FDA Commissioner weighs in Medicare's involvement in GLP-1 prices GLP-1 Pipeline Update: August 2025

Some patients have reported persistent gastrointestinal symptoms and, in more serious cases, medically confirmed gastroparesis (stomach paralysis)

When a new prescription drug enters the market, the question for employers isnt just does it work? Its what does covering it mean for our people, our plan, and our longterm costs? That question became especially relevant in early 2026, when an oral version of Wegovy entered the market with widespread media coverage

If you are comparing your options across the full GLP-1 landscape, the semaglutide vs tirzepatide comparison provides context for both injectable and oral formats

[DOI] [PMC free article] [PubMed] [Google Scholar] El Bekay R., Con-Aragez L., Fernndez-Garca D., Oliva-Olivera W., Bernal-Lpez R., Clemente-Postigo M., et al

Amazon Pharmacy is moving prescriptions from behind the counter to fully digital, on demand access

Launched as an extension of its existing No Worries line, the brand is all about fibre, thanks to its content of chicory root fibre for digestive support